from Piper Sandler issued a price target of $390.00 for DAVE on 2026-08-17 08:41:10.The adjusted price target was set to $390.00.At the time of the announcement, DAVE was trading at $334.57.The overall price target consensus is at $434.00 with high price of $475.00, low price of $310.00, and median price is at $450.00.DAVE currently trades...
Piper Sandler analyst issues OVERWEIGHT recommendation for DAVE on August 17, 2026 08:41AM ET. The previous...
Top Ships Inc. (TOPS) - This analysis reviews how the stock price reacted after the last...
Sunlands Technology Group (STG) - This analysis reviews how the stock price reacted after the last...
X Financial (XYF) - This analysis reviews how the stock price reacted after the last 12...
from Piper Sandler issued a price target of $390.00 for DAVE on 2026-08-17 08:41:10.The adjusted price target was set to $390.00.At the time of the announcement, DAVE was trading at...
from Jefferies issued a price target of $1.90 for GEVO on 2026-08-14 20:44:25.The adjusted price target was set to $1.90.At the time of the announcement, GEVO was trading at $1.69.The...
from Roth Capital issued a price target of $3.60 for GNSS on 2026-08-14 18:30:10.The adjusted price target was set to $3.60.At the time of the announcement, GNSS was trading at...
from Industrial Alliance Securities issued a price target of $15.00 for ABEO on 2026-08-14 16:13:37.The adjusted price target was set to $15.00.At the time of the announcement, ABEO was trading...
Scott Henry from Industrial Alliance Securities issued a price target of $1.90 for QSI on 2026-08-14 13:24:41.The adjusted price target was set to $1.90.At the time of the announcement, QSI...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
